Open label trials are seen as scary though. And understandable, it’s just shy of being fully approved and sent off as a big guy. However there’s a lot of stigma that surrounds this that leads to misinformation. https://t.co/kqWj7rLQVf
Reducing bias in open-label trials where blinded outcome assessment is not feasible https://t.co/8e9wLPoru3 #trialsjournal
Reducing bias when you can't blind outcome assessment: 2 egs from surgery http://t.co/mJxkRqvmJb
Reducing bias when you can't blind outcome assessment: 2 egs from surgery http://t.co/mJxkRqvmJb